# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Citigroup analyst Joanne Wuensch upgrades Edwards Lifesciences (NYSE:EW) from Neutral to Buy and raises the price target fro...
Edwards Lifesciences faces EU antitrust complaint from Meril over patent disputes, intensifying regulatory scrutiny. Recent act...
Deutsche Bank analyst Pito Chickering upgrades Edwards Lifesciences (NYSE:EW) from Hold to Buy and raises the price target f...
- Reuters
Barclays analyst Matt Miksic maintains Edwards Lifesciences (NYSE:EW) with a Overweight and raises the price target from $10...
Cramer likes Delta Air Lines, United Airlines Holdings. "Now, remember, they're very inexpensive stocks, but they trade...